These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
807 related articles for article (PubMed ID: 31306767)
1. Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism. Kuwata H; Hara S Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106363. PubMed ID: 31306767 [TBL] [Abstract][Full Text] [Related]
2. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages. Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475 [TBL] [Abstract][Full Text] [Related]
3. Role of long-chain acyl-coenzyme A synthetases in the regulation of arachidonic acid metabolism in interleukin 1β-stimulated rat fibroblasts. Kuwata H; Yoshimura M; Sasaki Y; Yoda E; Nakatani Y; Kudo I; Hara S Biochim Biophys Acta; 2014 Jan; 1841(1):44-53. PubMed ID: 24095834 [TBL] [Abstract][Full Text] [Related]
4. Role of long-chain acyl-CoA synthetase 4 in formation of polyunsaturated lipid species in hepatic stellate cells. Tuohetahuntila M; Spee B; Kruitwagen HS; Wubbolts R; Brouwers JF; van de Lest CH; Molenaar MR; Houweling M; Helms JB; Vaandrager AB Biochim Biophys Acta; 2015 Feb; 1851(2):220-30. PubMed ID: 25500141 [TBL] [Abstract][Full Text] [Related]
5. Analysis on the Substrate Specificity of Recombinant Human Acyl-CoA Synthetase ACSL4 Variants. Shimbara-Matsubayashi S; Kuwata H; Tanaka N; Kato M; Hara S Biol Pharm Bull; 2019; 42(5):850-855. PubMed ID: 31061331 [TBL] [Abstract][Full Text] [Related]
6. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder. Shimshoni JA; Basselin M; Li LO; Coleman RA; Rapoport SI; Modi HR Biochim Biophys Acta; 2011 Mar; 1811(3):163-9. PubMed ID: 21184843 [TBL] [Abstract][Full Text] [Related]
7. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516 [TBL] [Abstract][Full Text] [Related]
8. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction. Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618 [TBL] [Abstract][Full Text] [Related]
9. Role of ACSL4 in the chemical-induced cell death in human proximal tubule epithelial HK-2 cells. Kuwata H; Tomitsuka Y; Yoda E; Hara S Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35103282 [TBL] [Abstract][Full Text] [Related]
10. Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4. Modi HR; Basselin M; Rapoport SI Bipolar Disord; 2014 Dec; 16(8):875-80. PubMed ID: 25041123 [TBL] [Abstract][Full Text] [Related]
11. Myeloid-Specific Deficiency of Reeves AR; Sansbury BE; Pan M; Han X; Spite M; Greenberg AS J Immunol; 2021 Dec; 207(11):2744-2753. PubMed ID: 34725110 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway. Kuwata H; Hara S Biochem Biophys Res Commun; 2015 Sep; 465(3):528-33. PubMed ID: 26282205 [TBL] [Abstract][Full Text] [Related]
13. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. Maloberti PM; Duarte AB; Orlando UD; Pasqualini ME; Solano AR; López-Otín C; Podestá EJ PLoS One; 2010 Nov; 5(11):e15540. PubMed ID: 21085606 [TBL] [Abstract][Full Text] [Related]
15. Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder. Modi HR; Basselin M; Taha AY; Li LO; Coleman RA; Bialer M; Rapoport SI Biochim Biophys Acta; 2013 Apr; 1831(4):880-6. PubMed ID: 23354024 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4. Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867 [TBL] [Abstract][Full Text] [Related]
17. The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells. Radif Y; Ndiaye H; Kalantzi V; Jacobs R; Hall A; Minogue S; Waugh MG Mol Cell Biochem; 2018 Nov; 448(1-2):275-286. PubMed ID: 29450800 [TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation. Kan CF; Singh AB; Stafforini DM; Azhar S; Liu J J Lipid Res; 2014 Aug; 55(8):1657-67. PubMed ID: 24879802 [TBL] [Abstract][Full Text] [Related]
19. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer. Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484 [TBL] [Abstract][Full Text] [Related]
20. Identification of p115 as a novel ACSL4 interacting protein and its role in regulating ACSL4 degradation. Sen P; Kan CFK; Singh AB; Rius M; Kraemer FB; Sztul E; Liu J J Proteomics; 2020 Oct; 229():103926. PubMed ID: 32736139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]